Page 2 - Affinity Technologies News Today

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its peers? We will compare bioAffinity Technologies to similar companies based on the strength of its profitability, dividends, risk, valuation, earnings, institutional ownership and analyst recommendations. Insider & Institutional Ownership […]

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare bioAffinity Technologies to similar companies based on the strength of its earnings, dividends, risk, valuation, analyst recommendations, profitability and institutional ownership. Earnings and […]

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 73 publicly-traded companies in the “Diagnostics & Research” industry, but how does it contrast to its competitors? We will compare bioAffinity Technologies to similar companies based on the strength of its profitability, institutional ownership, valuation, earnings, risk, analyst recommendations and dividends. Risk and Volatility bioAffinity […]

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 73 publicly-traded companies in the “Diagnostics & Research” industry, but how does it compare to its competitors? We will compare bioAffinity Technologies to related companies based on the strength of its analyst recommendations, valuation, risk, dividends, institutional ownership, profitability and earnings. Analyst Recommendations This is […]

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) is one of 39 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare bioAffinity Technologies to related companies based on the strength of its institutional ownership, dividends, profitability, valuation, analyst recommendations, earnings and risk. Insider and […]

BioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 1,600 shares, an increase of 700.0% from the March 15th total of 200 shares. Based on an average daily volume of 3,100 shares, the short-interest ratio […]

BioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the target of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 1,600 shares, a growth of 700.0% from the March 15th total of 200 shares. Based on an average trading volume of 3,100 shares, […]

BioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totalling 1,600 shares, an increase of 700.0% from the March 15th total of 200 shares. Based on an average trading volume of 3,100 shares, the days-to-cover ratio […]

BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced the expansion of...

BioAffinity Technologies (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from…